SIO_901250-22WebSocialGraphics.jpg

SIO2023 Annual Scientific Meeting

Go Beyond the Science—Make Connections & Build Your Practice with IO Essentials at SIO2023



The SIO2023 IO Essentials Scholarship application is now closed and recipients have been notified.

SIO is thrilled to present IO Essentials, the premier event for early career interventional oncologists.

IO Essentials prepares you for a strong career by connecting you with the most successful interventional oncologists in the field and presenting on-demand courses dedicated to practice building.

By attending this event, you will:

  • Collect tips and technical how-to’s for building a successful clinical practice and career in IO
  • Expand your network, including peers and pioneers in the field
  • Get up to speed on cutting-edge IO research and treatment algorithms
  • Understand the latest clinical and translational research as it relates to patient care


What Does the Scholarship Include?

  • Stipend for travel expenses to the SIO2023 Annual Scientific Meeting ($200 local, $750 North America, and $1,000 international applicants) 
  • One year of complimentary membership to SIO
  • Access to the SIO2023 IO Essentials Program 
  • Exclusive invitations to events with industry leaders

2023 IO Essentials Program

The session information listed here is subject to change. This page was last updated 21 January 2023.

* Required programming, + Recommended programming

Thursday 19 January 2023

Time (EST)

Session Title

7:30am - 8:00am IO Essentials Breakfast *
8:00am - 9:00am

IO Essentials: Opening Session

Moderators: Isabel Newton, MD, USCSD; Vijay Ramalingam, MD, BIDMC

  • Palliative Care & Compassionate Communication, Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego
  • Ethics & Consent, Helena D. Rockwell, BSc, University of California San Diego
  • Y90 Basics, Zach Berman, MD, University of California San Diego
9:00am - 10:30am IO Essentials Sponsored Content Presented by Boston Scientific
10:30am - 11:15am Break
11:15am - 12:45pm IO Essentials Sponsored Content Presented by Varian, a Siemens Healthineers Company
12:45pm - 1:15pm Lunch
1:15 pm - 2:45pm IO Essentials Sponsored Content Presented by NeuWave
3:00pm - 3:50pm

Getting Started in IO *

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Erica Alexander, MD, Memorial Sloan Kettering Cancer Center; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

  • History of IO & SIOWilliam Rilling, MD, FSIR, Medical College of Wisconsin
  • Types of Ablation Technology & How to SelectDavid Woodrum, MD, PhD, Mayo Clinic
  • Chemoembolization: Technique and Evidence, Sarah White, MD, MS, Medical College of Wisconsin
  • IO ResearchLynn Savic, MD, Universitatsmedizin Charite Berlin
3:50pm - 4:00pm Break
4:00pm - 4:30pm

Professional Development in Practice Setting *

Moderators: Alda Tam, MD, MD Anderson Cancer Center; Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego

  • Academic AchievementAlda Tam, MD, MD Anderson Cancer Center
  • MentorshipJulius Chapiro, MD, PhD, Yale University School of Medicine
  • Collaborating with Industry, Riad Salem, MD, MBA, Northwestern University
4:30pm - 4:35pm Break
4:35pm - 5:35pm

Preparing for Tumor Boards *

Moderators: William Rilling, MD, FSIR, Medical College of Wisconsin; Riad Salem, MD, MBA, Northwestern University

  • Practice BuildingWilliam Rilling, MD, FSIR, Medical College of Wisconsin
  • IO Cliffnotes: LiverJoseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
  • IO Cliffnotes: Other, Rob Suh, MD, Ronald Reagan UCLA Medical Center
  • NCCN GuidelinesSarah White, MD, MS, Medical College of Wisconsin
  • Collaborating with Other SpecialtiesRon Arellano, MD, Massachusetts General Hospital
5:35pm - 6:00pm Break
6:00pm - 7:00pm

Tumor Board *

Moderators: Riad Salem, MD, MBA, Northwestern University; Sarah White, MD, MS, Medical College of Wisconsin

Panelists: Ron Arellano, MD, Massachusetts General Hospital; Marina Baretti, MD, Johns Hopkins University; Jennifer Berumen. MD, University of California San Diego

Friday 20 January 2023

Time (EST)

Session Title

7:45am - 8:30am

Breakfast & Industry Symposium Presented by Stryker - Bone Tumor Ablation with Stryker's OptaBlate System *

  • Reade De Leacy, MD, Mount Sinai
8:30am - 9:00am Break
9:00am - 10:00am

President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture*

  • President's Welcome, Matthew Callstrom, MD, PhD, Mayo Clinic
  • Meeting Intro & ThanksDamian Dupuy, MD, FACR, Cape Cod Hospital
  • Laudation, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
  • Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, Prof. S. Nahum Goldberg, MD, Hadassah Hebrew University Medical Center
10:00am - 11:00am

Patient-Centered IO Care *

Moderator: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

  • Whole Patient Approach to IOIsabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
  • Extending Life & Living with Chronic Cancer, Angela Laffan, NP, MSN, University of California San Francisco
  • Death & Dying: Realistic Expectations, Cristal Brown, MD, MHS, University of Texas at Austin Dell Medical School
  • Caring for Those Who Care: Families & Physicians, Janice Newsome, MD, Emory University
  • Survivorship: Patient Perspective, Lynn Lazzaro, Valley Advisors
11:00am - 11:30am

Expo Hall Break - Discovery Theater Presentation by Guerbet +

HCC Managment in 2023: Moving Towards a More Targeted Treatment Delivery, Pav Najran, MD

11:30am - 12:30pm

Immuno-oncology +

Moderators: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center

  • Basics of Immunology, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Immunoadjuvants for AblationIsabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
  • Tumor DNA Research, Mark Yarchoan, MD, Johns Hopkins Univesity
  • Immunotherapy Pipeline, Gordon Cohen, MD, AstraZeneca
12:45pm - 1:30pm

Lunch & Industry Symposium Presented by Boston Scientific - State-of-the-Art Locoregional Therapies for Liver and Lung *

  • Robert Suh, MD, Ronald Reagan UCLA Medical Center
  • Beau Toskich, MD, Mayo Clinic

Lunch & Industry Symposium Presented by Guerbet - Optimize Your Treatment Delivery in HCC *

  • Introduction, Mike Devane, MD, Greenville Memorial Hospital
  • How I Improve Selective Treatment in TARE?, Pav Najran, MD
  • How I Deliver with More Precision in DEB-TACE?, Mike Devane, MD, Greenville Memorial Hospital
1:30pm - 2:00pm

Expo Hall Afternoon Hours - Discovery Theater Presentation by Genentech +

Advancement in the 1L Treatment of Unresectable or Metastatic HCC, Ripal Gandhi, MD

2:00pm - 3:00pm

State of the Art SIO Trials +

Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

  • EMERALD1, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Imaging Tumor Microenvironments SIO Grant Update, Julius Chapiro, MD, PhD, Yale University School of Medicine
  • Immunology SIO Grant Update, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
  • Lipiodol SIO Grant Update, Rony Avritscher, MD, MD Anderson Cancer Center
  • ACCLAIM, Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center
3:00pm - 4:00pm

Expo Hall Networking & Oral Poster Presentations +

  • Computed Tomography-Guided Percutaneous Microwave Ablation for Renal Cell Carcinoma: Evaluation of Morphological factors affecting the outcome, Ornella Moschovaki-Zeiger, MD, "Attikon" University General Hospital of Athens/Greece
  • Safety and efficacy of histotripsy delivery through overlying gas-filled bowel in an ex vivo swine model, Meredith Kisting, MA, University of Wisconsin
  • The Diagnostic Value of Transcatheter CTHA for Intraprocedural Detection of previously unknown CRLM during Percutaneous Ablation and Impact on Treatment plan, Susan van der Lei, MD, PhD, Amsterdam UMC
4:00pm - 5:00pm

Hands-On: Ablation *

5:15pm - 6:15pm

HCC/Cholangio Tumor Board*

Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard

Panelists: Zach Berman, MD, University of California San Diego; David Madoff, MD, Yale School of Medicine; Marina Baretti, MD, Johns Hopkins University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Jennifer Berumen. MD, University of California San Diego; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

6:15pm - 7:30pm Opening & Founding Members Reception in Expo Hall *

Saturday 21 January 2023

Time (EST)

Session Title

7:45am - 8:30am

Breakfast & Education Session - Optimal Preparation and Treatment Endpoints in cTACE *

  • Sarah White, MD, MS, Medical College of Wisconsin
  • William Rilling, MD, FSIR, Medical College of Wisconsin
  • Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
  • Nicholas Fidelman, MD, University of California San Francisco
8:30am - 9:00am Expo Hall Morning Hours +
9:00am - 10:00am

Y90 Radioembolization for Primary & Metastatic Liver Cancer: One Size Does Not Fit All +

Moderators: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute

  • Lung Shunt & Lung Dose Considerations, Marnix Lam, MD, PhD, University Medical Center Utrecht
  • Multi-Compartment Dosimetry, Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute
  • Dosimetry in Ablative Setting: Resin versus Glass, Beau Toskich, MD, Mayo Clinic
  • Dosimetry in Non-Ablative Setting: Resin versus Glass, Nima Kokabi, MD, Emory University
  • Post-Treatment Imaging: SPECT versus PET, Cheenu Kappadath, PhD, UT MD Anderson Cancer Center
10:00am - 11:00am

Scientific Oral Abstracts *

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

  • Bone Ablation with a Saline-Infused System, Amanda Smolock, MD, PhD, Medical College of Wisconsin
  • Radiomics-based predictive models for new intrahepatic tumors following thermal ablation of colorectal liver metastasis, Iwan Paolucci, PhD, The University of Texas MD Anderson Cancer Center
  • Is the minimal ablative margin measured on intraprocedural post-ablation CT better than first follow-up CT in predicting colorectal liver metastasis outcomes? Yuan-Mao Lin, MD, The University of Texas MD Anderson Cancer Center
  • Circulating miR-21 as a prognostic biomarker for HCC treated with CT-guided high-dose rate brachytherapy, Matthias Stechele, MD, University Hospital, LMU Munich
  • An injectable intratumoral immunoadjuvant depot overcomes check-point inhibitor resistant cancer at distant tumor sites through local immune system stimulation, Avik Som, MD, PhD, MGH
  • MRI-guided trans-perineal focal cryoablation for primary prostate cancer, Aliza Mushtaq, MD, Mayo Clinic
  • Immediate 3D Imaging Assessment is the Most Accurate Predictor of Local Tumor Progression after Microwave Ablation of CRC Liver Metastases, Mahdi Zirakchian Zadeh, MD, Memorial Sloan Kettering Cancer Center
  • Development of Patient-Derived Hepatocellular Carcinoma (HCC) Tumoroids as a Platform for Preclinical Investigations of Liver-Directed Therapies, Christopher Malone, MD, Mallinckrodt Institute of Radiology at Washington University School of Medicine
11:00am - 11:30am

Expo Hall Break - Discovery Theater Presentation by Varian, a Siemens Healthineers Company +

Image-Guided Cryoablation and Embolization in MSK: MSK Intervention with Cryotherapy and Embolization Using Integrated Angio-CT Solutions, Rahul Anil Sheth, MD

11:30am - 12:30pm

Liver Directed Therapy for Early Stage HCC *

Moderators: Kelvin Hong, MD, Johns Hopkins University; Laura Crocetti, MD, PhD, University of Pisa

  • Surgical Approach, Andrew Cameron, MD, PhD, Johns Hopkins University
  • Arterial Approach, Kelvin Hong, MD, Johns Hopkins University
  • AblationLaura Crocetti, MD, PhD, University of Pisa
  • Radiation Oncology, Amol Narang, MD, Johns Hopkins University
12:45pm - 1:30pm

Lunch & Industry Symposium Presented by TriSalus - Seeking to Enable Immunotherapy for Liver and Pancreatic Tumors: Updates from PERIO Trials *

  • Steven Katz, MD, FACS, TriSalus Life Sciences
  • Alex Kim, MD, National Vascular Physicians
  • Rahul Sheth, MD, MD Anderson Cancer Center

Lunch & Industry Symposium Presented by Sirtex - Resin Y-90 Dosimetry: From Theory to Practice *

  • S. Cheenu Kappadath, PhD, MD Anderson Cancer Center
  • Nima Kokabi, MD, FRCP, Emory University
1:30pm - 2:00pm

Expo Hall Afternoon Hours - Discovery Theater Presentation by Varian, a Siemens Healthineers Company +

Is Access to Interventional Oncology Care in the US Equitable? Geographic Access to Interventional Oncology Care in the USA, Theresa M. Caridi, MD, FSIR

2:00pm - 3:00pm

Women & Under-Represented Minorities in IO *

Moderators: Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

  • Setting the Stage, Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
  • Changing the Pipeline, Culture & Environment, Amy Deipolyi, MD, PhD, West Virginia University & Sherri Reed, Research Fellow, NIH
  • Pigeonholing & Imposter SyndromeMaureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill & Kirema Garcia-Reyes, MD, Mount Sinai Hospital
  • He for She & Male PortraitureBrad Wood, MD, NIH & Nicole Varble, NIH
  • Panel Discussion

Planning Committee: Maureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill; Ji Buethe, MD, Johns Hopkins University; Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center; Erica Alexander, MD, Memorial Sloan Kettering Cancer Center; Sharon Kwan, MD, MS, Seattle Cancer Care Alliance

3:00pm - 4:00pm

Expo Hall Networking & Oral Poster Presentations +

  • Fusion-Guided Optical Molecular Imaging Liver Biopsy and Point-of-Care Tissue Assessment for Liver Neoplasms, Michael Kassin, MD, NIH
  • Microwave Ablation of Stage IA Non-Small Cell Lung Cancers Detected at Low Dose CT Lung Cancer Screening in US Veterans: Midterm Results, Ericson John Torralba, Wright State University Boonshoft School of Medicine
  • Rapid Diagnosis through IR Outpatient Clinic to Expedite Triage for Patients without a Cancer Diagnosis and Diffuse Imaging Findings Suggestive of Cancer, Suken Shah, MD, Memorial Sloan Kettering Cancer Center
4:00pm - 5:00pm

Hands-On: Navigation & Guidance *

5:15pm - 6:15pm

GU/Bone Tumor Board *

Moderators: Matthew Callstrom, MD, PhD, Mayo Clinic; Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens

Panelists: David Einstein, MD, Beth Israel Deaconess Medical Center; Steven Yevich, MD, MPH, MD Anderson Cancer Center; Damian DupuyMD, FACR, Cape Cod Hospital

6:15pm - 8:30pm Break
8:30pm - 10:30pm SIO Presents: DC After Dark - Trivia & Networking*

Sunday 22 January 2023

Time (EST)

Session Title

8:30am - 9:00am  Expo Hall Morning Hours +
9:00am - 10:00am

HCC New Horizons *

  • Introduction & LaudationJulius Chapiro, MD, PhD, Yale University School of Medicine
  • HCC New Horizons Keynote, David Madoff, MD, Yale School of Medicine
10:00am - 11:00am

Scientific Oral Abstracts *

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

  • Effect of injection rate on bead distribution and volume delivered during embolization in swine: Results from the AmCORE, Antonio Arrichiello, MD, National Institutes of Health
  • Optimizing patient selection for treating colorectal liver metastases with glass radioembolization plus chemotherapy: The EPOCH study, Riad Salem, MD, MBA, Northwestern University
  • Phase I Prospective Trial of TAS-102 (trifluridine and tipiracil) and Radioembolization for Chemo-refractory Colorectal Liver Metastases, Nicholas Fidelman, MD, University of California San Francisco
  • Enhanced Delivery of a TLR9 Type C Agonist SD-101 to Liver Tumors in the Oncopig using Pressure Enabled Drug Delivery (PEDD) Versus a Standard Endhole Catheter, Thomas Hullinger, PhD, TriSalus Life Sciences
  • Radiofrequency ablation induced tumor growth is suppressed by microRNA21 inhibition, Lukas Salvermoser, MD, University Hospital Munich
  • Clinical study of CalliSpheres microspheres drug-eluting bead-transarterial chemoembolization combined with sintilimab in the treatment of unresectable HCC, Vineel Inampudi, Health Care Global Cancer Hospital
  • MRI Radiomics Correlate with Clinical Outcomes of Peripheral Venous Malformations Following Percutaneous Sclerotherapy, Adham Khalil, MD, Johns Hopkins University
  • Does Cancer Type Influence the Rate of Port Associated Infection? Alirezsa Zandifar, MD, Children's Hospital of Philadelphia
11:00am - 12:30pm Expo Hall Walk Through *
12:45pm - 1:30pm

Lunch & Industry Symposium Presented by AstraZeneca - Newly Approved Treatment Options for Unresectable Hepatocellular Carcinoma *

  • Bassam Estfan, MD, Cleveland Clinic

Lunch & Education Session - HCC Imaging and Chemoembolization 2023: New Techniques, New Science *

Moderator: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

  • Latest Guidelines and Randomized Trials, Lambros Tselikas, MD, Gustave Roussy
  • Biomarkers in Liver Cancer TherapyJulius Chapiro, MD, PhD, Yale University School of Medicine
1:30pm - 2:00pm

Expo Hall Afternoon Hours - Discovery Theater Presentation by Instylla +

Embrace (TM) HES for Tumor Embolization, Stephen Hunt, MD

2:00pm - 3:00pm

Lung Cancer & Mets +

Moderators: Stephen Hunt, MTR, MD, PhD, University of Pennsylvania; Alda Tam, MD, MD Anderson Cancer Center

  • Cutting Edge Clinical Trials in Lung AblationAlda Tam, MD, MD Anderson Cancer Center
  • Combination Immunotherapy, Damian Dupuy, MD, FACR, Cape Cod Hospital
  • Oligonodular Disease: Changing LandscapeMuneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
  • Thermal Therapy Considerations, Beau Toskich, MD, Mayo Clinic
  • Hot Topics in Trial Design for Minimally Invasive ProceduresFlorian Fintelmann, MD, Massachusetts General Hospital
3:00pm - 4:00pm

Expo Hall Networking & Oral Poster Presentations +

  • Clinical Feasibility of CT-based Dosimetry in Yttrium-90 Radioembolization Following the Administration of Radiopaque Glass Microspheres (Eye90), Robert Abraham, MD, Dalhousie University
  • Targeting for Transcostal Histotripsy: Effect of Intervening Ribs on the Location of Cavitation, Katrina Falk, MS, University of Wisconsin-Madison
  • Temporary Transvenous Pacer to Avoid Hypertensive Crisis during Percutaneous Ablation of Adrenal Metastasis: a single-center experience, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
4:00pm - 5:00pm

Hands-On: Treatment Planning & Simulation *

5:15pm - 6:15pm

Liver Mets Tumor Board *

Moderators: Edward Kim, MD, Mount Sinai Health Systems; Nora Tabori, MD, MedStar

Panelists: Kelly Lafaro, Md, Johns Hopkins University; Mary Mulcahy, MD, Northwestern University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Nicholas Fidelman, MD, University of California San Francisco; Bruno Odisio, MD, FSIR, MD Anderson Cancer Center

6:15pm - 7:00pm Break
7:00pm - 9:00pm *Sunday Soiree @ Jack Rose Dining Saloon +
*Social Event attendance requires an additional fee.

Monday 23 January 2023

Time (EST)

Session Title

9:00am - 10:00am

Technology +

Moderators: Joseph Amaral, MD, Histosonics; Damian Dupuy, MD, FACR, Cape Cod Hospital

  • Pulsed Electrical Fields, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
  • Histotripsy, Timothy Ziemlewicz, MD, UW Madison
  • Robotic Endoscopy for Lung CancerMichael Pritchett, DO, MPH, Pinehurst Medical
  • Bronchoscopic Lung Microwave Ablation, Michael Pritchett, DO, MPH, Pinehurst Medical
  • Treatment Planning, Punit Prakash, PhD, Kansas State University
10:00am - 10:15am Break
10:15am - 12:15pm

Case-Based Review +

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; R. Peter Lokken, MD, MPH, FSIR, University of California San Francisco

  • Liver Embolization, Christos Georgiades, MD, PhD, Johns Hopkins University
  • Liver AblationBruno Odisio, MD, FSIR, MD Anderson Cancer Center
  • RenalRyan Kohlbrenner, MD, University of California San Francisco
  • LungJi Buethe, MD, Johns Hopkins University
  • MSK, A. Nick Kurup, MD, Mayo Clinic
  • Complications: MissR. Peter Lokken, MD, MPH, FSIR, University of California San Francisco
  • Complications: Save, Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center
12:15pm - 12:30pm

Closing Remarks +

Matthew Callstrom, MD, PhD, Mayo Clinic